Franz Bracher holds a chair for Medicinal chemistry, he is an expert in the design and optimization of low-molecular drug candidates. Within the project his group focuses on the hit-to-lead optimization of drug-like compounds and natural products binding to conserved RNA regulatory elements in the SARS-CoV-2 genome, especially 5_SL1, by strategic structural modifications.
hello world!
Published: July 11, 2022
